1,142
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

Nanoparticles for the delivery of zoledronic acid to prostate cancer cells: A comparative analysis through time lapse video-microscopy technique

, , , , , , , , & ORCID Icon show all
Pages 1524-1532 | Received 06 Jun 2014, Accepted 28 Jul 2014, Published online: 16 Dec 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sarah A. Holstein. (2019) A patent review of bisphosphonates in treating bone disease. Expert Opinion on Therapeutic Patents 29:5, pages 315-325.
Read now

Articles from other publishers (12)

Maryam Khayati, Hamidreza Kheiri Manjili, Masoud Soleimani, Simzar Hosseinzadeh, Mohammad Akrami, Ismaeil Haririan & Seyed Hossein Ahmadi Tafti. (2023) Microfluidic synthesis of zoledronic acid loaded chitosan nanoparticles used for osteogenic differentiation of mesenchymal cells. International Journal of Biological Macromolecules 234, pages 123056.
Crossref
Wanxiao Sun, Yaxin Deng, Meihui Zhao, Ying Jiang, Jingxin Gou, Yanjiao Wang, Tian Yin, Yu Zhang, Haibing He & Xing Tang. (2021) Targeting therapy for prostate cancer by pharmaceutical and clinical pharmaceutical strategies. Journal of Controlled Release 333, pages 41-64.
Crossref
Patrícia de Faria Lainetti, Antonio Fernando Leis-Filho, Renee Laufer-Amorim, Alexandre Battazza & Carlos Eduardo Fonseca-Alves. (2020) Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems. Pharmaceutics 12:12, pages 1193.
Crossref
Lianwei Wang, Dengyang Fang, Jinming Xu & Runlan Luo. (2020) Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review. BMC Cancer 20:1.
Crossref
Maria Raffaella Zocchi, Francesca Tosetti, Roberto Benelli & Alessandro Poggi. (2020) Cancer Nanomedicine Special Issue Review Anticancer Drug Delivery with Nanoparticles: Extracellular Vesicles or Synthetic Nanobeads as Therapeutic Tools for Conventional Treatment or Immunotherapy. Cancers 12:7, pages 1886.
Crossref
Manpreet Sambi, Leila Bagheri & Myron R. Szewczuk. (2019) Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates. Journal of Oncology 2019, pages 1-12.
Crossref
John L. Collins, Bart van Knippenberg, Kai Ding & Alexander V. Kofman. 2019. Cell Culture. Cell Culture.
Daniel W. Fowler, John Copier, Angus G. Dalgleish & Mark D. Bodman-Smith. (2017) Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2+ γδ T cell cytotoxicity in a perforin-dependent manner. Cancer Immunology, Immunotherapy 66:9, pages 1205-1215.
Crossref
Xu Li, Youssef W. Naguib, Solange Valdes, Stephanie Hufnagel & Zhengrong Cui. (2017) Reverse Microemulsion-Based Synthesis of (Bis)phosphonate–Metal Materials with Controllable Physical Properties: An Example Using Zoledronic Acid–Calcium Complexes. ACS Applied Materials & Interfaces 9:16, pages 14478-14489.
Crossref
Joanna Kopecka, Stefania Porto, Sara Lusa, Elena Gazzano, Giuseppina Salzano, Martha Leonor Pinzòn-Daza, Antonio Giordano, Vincenzo Desiderio, Dario Ghigo, Giuseppe De Rosa, Michele Caraglia & Chiara Riganti. (2016) Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors. Oncotarget 7:15, pages 20753-20772.
Crossref
Heleen H. Van Acker, Sébastien Anguille, Yannick Willemen, Evelien L. Smits & Viggo F. Van Tendeloo. (2016) Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials. Pharmacology & Therapeutics 158, pages 24-40.
Crossref
Joanna Kopecka, Stefania Porto, Sara Lusa, Elena Gazzano, Giuseppina Salzano, Antonio Giordano, Vincenzo Desiderio, Dario Ghigo, Michele Caraglia, Giuseppe De Rosa & Chiara Riganti. (2015) Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells. Oncotarget 6:31, pages 31461-31478.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.